A Rebeccamycin Analog Provides Plasmid-Encoded Niche Defense

Area of Science:

• Microbiology
• Chemical Biology
• Ecology

Background:

• Bacterial symbionts in fungus-growing ants face competition from other bacterial strains.
• Indolocarbazoles, like rebeccamycin, are an important class of natural products with antitumor properties.
• Previous metagenomic studies suggested the existence of modified indolocarbazoles, but the metabolites remained undiscovered.

Purpose of the Study:

• To investigate the small molecules involved in bacterial competition within the fungus-growing ant symbiosis.
• To identify and characterize novel natural products produced by these specialized bacteria.
• To elucidate the biosynthetic pathway of a newly discovered indolocarbazole analog.

Main Methods:

• Culturing of bacterial symbionts from fungus-growing ants.
• Metabolomic analysis to identify novel small molecules.
• Genomic and bioinformatic analysis to identify biosynthetic gene clusters.
• Chemical synthesis and structural elucidation of the identified compound.

Main Results:

• Discovery and characterization of 9-methoxyrebeccamycin, an analog of rebeccamycin.
• Identification of the complete biosynthetic gene cluster for 9-methoxyrebeccamycin.
• The biosynthetic gene cluster is plasmid-encoded, similar to other antimicrobial peptide systems.
• The newly discovered molecule is produced by bacterial symbionts of fungus-growing ants.

Conclusions:

• 9-methoxyrebeccamycin is a novel indolocarbazole produced by ant-associated bacteria.
• The plasmid-encoded biosynthetic pathway suggests a role in inter-bacterial antagonism.
• This discovery sheds light on the chemical ecology and competition dynamics in specialized microbial communities.